Iverson Genetic Diagnostics Inc — Form D
Iverson Genetic Diagnostics Inc of Seattle, WA, a company, filed a Form D exempt-offering notice with the SEC on 2014-10-09. The offering totals $5.0M, of which $20K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2014-10-09
- Form: D
- Accession: 0001417699-14-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $5.0M
- Amount sold: $20K
- Remaining: $5.0M
- Minimum investment: $10K
- Investors: 1
- Date of first sale: 2014-10-07
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-226161
Issuer
- Name: Iverson Genetic Diagnostics Inc
- CIK: 0001417699
- Entity type: Corporation
- Jurisdiction: NEVADA
- Incorporated: 2007
- Address: 401 Terry Avenue North, Seattle, WA, 98109
- Phone: 206-946-6000
Officers, directors & promoters (15)
| Name | Role | Location |
|---|
| David C Michaels | Director | Seattle, WA |
| Doranne Satterlee | Director | Seattle, WA |
| Harvey Schiller | Director | New York, NY |
| Tom Siggia | Director | Seattle, WA |
| Dean Sproles | Director | Charleston, SC |
| Jeff Nyweide | Executive Officer | Seattle, WA |
| Yelena Shevelenko | Executive Officer | Seattle, WA |
| Leroy Hood | Director | Culver City, CA |
| Dean Sproles | Executive Officer | Charleston, SC |
| Doranne Satterlee | Executive Officer | Seattle, WA |
| Thomas J Siggia | Director | Bothell, WA |
| Frank R Ecock | Director | Bothell, WA |
| Frank Ecock | Director | Bothell, WA |
| Bob Quillinan | Executive Officer | Bothell, WA |
| Christopher Dubay | Director | Bothell, WA |
Other filings by this issuer (8)
More